JP2021008481A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021008481A5 JP2021008481A5 JP2020164124A JP2020164124A JP2021008481A5 JP 2021008481 A5 JP2021008481 A5 JP 2021008481A5 JP 2020164124 A JP2020164124 A JP 2020164124A JP 2020164124 A JP2020164124 A JP 2020164124A JP 2021008481 A5 JP2021008481 A5 JP 2021008481A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- medicament according
- tumor
- time
- gitrl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022112196A JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562101850P | 2015-01-09 | 2015-01-09 | |
| US62/101,850 | 2015-01-09 | ||
| US201562126300P | 2015-02-27 | 2015-02-27 | |
| US62/126,300 | 2015-02-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536882A Division JP2018504403A (ja) | 2015-01-09 | 2016-01-08 | 悪性腫瘍の治療に対する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022112196A Division JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021008481A JP2021008481A (ja) | 2021-01-28 |
| JP2021008481A5 true JP2021008481A5 (enExample) | 2021-05-06 |
| JP7111384B2 JP7111384B2 (ja) | 2022-08-02 |
Family
ID=56356515
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536882A Pending JP2018504403A (ja) | 2015-01-09 | 2016-01-08 | 悪性腫瘍の治療に対する方法 |
| JP2020164124A Active JP7111384B2 (ja) | 2015-01-09 | 2020-09-29 | 悪性腫瘍の治療に対する方法 |
| JP2022112196A Pending JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536882A Pending JP2018504403A (ja) | 2015-01-09 | 2016-01-08 | 悪性腫瘍の治療に対する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022112196A Pending JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20180000895A1 (enExample) |
| EP (2) | EP3242947B1 (enExample) |
| JP (3) | JP2018504403A (enExample) |
| CA (1) | CA2973390A1 (enExample) |
| DK (1) | DK3242947T3 (enExample) |
| ES (1) | ES2809734T3 (enExample) |
| MX (1) | MX383277B (enExample) |
| PL (1) | PL3242947T3 (enExample) |
| WO (1) | WO2016112359A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2809734T3 (es) * | 2015-01-09 | 2021-03-05 | Oncosec Medical Inc | Terapia génica y electroporación para el tratamiento de neoplasias malignas |
| EP4209190A1 (en) | 2016-06-27 | 2023-07-12 | Galvanize Therapeutics, Inc. | System comprising a generator and a catheter with an electrode for treating a lung passageway |
| US12403305B2 (en) | 2016-06-27 | 2025-09-02 | Galvanize Therapeutics, Inc. | Immunostimulation in the treatment of viral infection |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| JP2021508533A (ja) | 2017-12-26 | 2021-03-11 | ギャラリー，インコーポレイテッド | 様々な用途のためのエネルギー送達の最適化 |
| MX2020011618A (es) * | 2018-05-02 | 2021-02-16 | Oncosec Medical Inc | Sistemas, métodos y aparatos de electroporación. |
| KR102753455B1 (ko) * | 2018-08-08 | 2025-01-10 | 세다르스-신나이 메디칼 센터 | 암 및 자가면역 질환을 치료하기 위한 조성물 및 방법 |
| JP7586890B2 (ja) | 2019-07-16 | 2024-11-19 | ガルヴァナイズ セラピューティクス，インコーポレイテッド | パルス電界による生殖器の治療 |
| CN114127121B (zh) | 2019-08-12 | 2025-04-11 | 北京恩瑞尼生物科技股份有限公司 | 用于通过cd39表达细胞的adcc靶向促进和增强t细胞介导的免疫反应的方法和组合物 |
| TW202128775A (zh) | 2019-10-16 | 2021-08-01 | 英商阿法克塔生命科學有限公司 | PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分 |
| GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
| WO2022234003A1 (en) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Cd33 binding polypeptides with stefin a protein |
| EP4413038A1 (en) | 2021-10-07 | 2024-08-14 | Avacta Life Sciences Limited | Pd-l1 binding affimers |
| TW202332694A (zh) | 2021-10-07 | 2023-08-16 | 英商阿凡克塔生命科學公司 | 血清半衰期延長之ｐｄ－ｌ１結合多肽 |
| CN119213021A (zh) | 2022-02-10 | 2024-12-27 | 艾菲赛尔治疗株式会社 | 与CD40L特异性结合的Stefin A蛋白变体及其用途 |
| KR20250006965A (ko) | 2022-04-29 | 2025-01-13 | 퓨리노미아 바이오테크, 아이엔씨. | 호산구에 의해 유발되는 질환 및 장애의 치료를 위한 방법 및 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5993434A (en) * | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
| US20030049696A1 (en) | 2001-06-07 | 2003-03-13 | Norment Anne M. | Regulatory T cells and uses thereof |
| US8209006B2 (en) | 2002-03-07 | 2012-06-26 | Vgx Pharmaceuticals, Inc. | Constant current electroporation device and methods of use |
| US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
| US20110142887A1 (en) * | 2009-12-15 | 2011-06-16 | Immunovative Therapies Ltd. | Methods and compositions for liquidation of tumors |
| US8802643B1 (en) * | 2003-05-30 | 2014-08-12 | University Of South Florida | Method for the treatment of malignancies |
| EA200501937A1 (ru) * | 2003-05-30 | 2006-08-25 | Университет Южной Флориды | Способ лечения злокачественных опухолей |
| US7923251B2 (en) | 2005-02-23 | 2011-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for avalanche-mediated transfer of agents into cells |
| US8101169B2 (en) | 2005-02-23 | 2012-01-24 | The Board Of Trustees Of The Leland Stanford Junior University | Ocular gene therapy using avalanche-mediated transfection |
| WO2007120368A2 (en) * | 2006-01-09 | 2007-10-25 | The Regents Of The University Of California | Immunostimulatory combinations for vaccine adjuvants |
| WO2010030002A1 (ja) * | 2008-09-12 | 2010-03-18 | 国立大学法人三重大学 | 外来性ｇｉｔｒリガンド発現細胞 |
| KR102445129B1 (ko) * | 2011-12-12 | 2022-09-20 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법 |
| ES2809734T3 (es) * | 2015-01-09 | 2021-03-05 | Oncosec Medical Inc | Terapia génica y electroporación para el tratamiento de neoplasias malignas |
-
2016
- 2016-01-08 ES ES16735524T patent/ES2809734T3/es active Active
- 2016-01-08 EP EP16735524.7A patent/EP3242947B1/en active Active
- 2016-01-08 PL PL16735524T patent/PL3242947T3/pl unknown
- 2016-01-08 DK DK16735524.7T patent/DK3242947T3/da active
- 2016-01-08 WO PCT/US2016/012759 patent/WO2016112359A1/en not_active Ceased
- 2016-01-08 EP EP20176001.4A patent/EP3799879B1/en active Active
- 2016-01-08 JP JP2017536882A patent/JP2018504403A/ja active Pending
- 2016-01-08 MX MX2017009044A patent/MX383277B/es unknown
- 2016-01-08 CA CA2973390A patent/CA2973390A1/en active Pending
- 2016-01-08 US US15/542,415 patent/US20180000895A1/en not_active Abandoned
-
2020
- 2020-09-29 JP JP2020164124A patent/JP7111384B2/ja active Active
-
2022
- 2022-07-13 JP JP2022112196A patent/JP2022137203A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021008481A5 (enExample) | ||
| Sersa et al. | Electrochemotherapy in treatment of tumours | |
| Mir | Bases and rationale of the electrochemotherapy | |
| Panje et al. | Electroporation therapy of head and neck cancer | |
| AU2007224275B2 (en) | Method and device for treating microscopic residual tumors remaining in tissues following surgical resection | |
| US6697670B2 (en) | Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients | |
| P Spugnini et al. | Electrochemotherapy as first line cancer treatment: experiences from veterinary medicine in developing novel protocols | |
| Fregni et al. | Effects of transcranial direct current stimulation coupled with repetitive electrical stimulation on cortical spreading depression | |
| JP2019500170A5 (enExample) | ||
| US20120283502A1 (en) | Ultrasound neuromodulation treatment of depression and bipolar disorder | |
| Vlaicu et al. | New neuromodulation techniques for treatment resistant depression | |
| Cha et al. | Plasmid IL-12 electroporation in melanoma | |
| Burnette et al. | The immunology of ablative radiation | |
| NO922441L (no) | Fremgangsmaate og apparat for pulset, iontoforetisk avgivelse av medikamenter | |
| CN116867544A (zh) | 通过在少于一半的时间在峰值强度处施加肿瘤治疗场（TTField）来增加TTField的功效 | |
| US20240100326A1 (en) | Method for changing blood brain barrier permeability | |
| Yanagisawa et al. | Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75) | |
| Giannola et al. | Physical methods to promote drug delivery on mucosal tissues of the oral cavity | |
| Vásquez et al. | In vitro and in vivo experiments on electrochemotherapy for bladder cancer | |
| CN107185107A (zh) | 一种超声直流电离子导入系统 | |
| Spinks et al. | Problem of dural scarring in recording from awake, behaving monkeys: a solution using 5-fluorouracil | |
| Miyazaki et al. | Possible involvement of antitumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin | |
| Shiasi et al. | The study of pain types, its inhibitory methods and tens effect on pain | |
| Cemazar et al. | 24 Electroporation for Electrochemotherapy and Gene Therapy | |
| WO2009126642A8 (en) | High-energy anti-tachycardia therapy |